Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTranslational
Open Access

Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy

Giulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, Lara Struelens, Julie Nonnekens, Marion De Jong, Mark W. Konijnenberg and Carmen Villagrasa
Journal of Nuclear Medicine May 2022, 63 (5) 761-769; DOI: https://doi.org/10.2967/jnumed.121.262610
Giulia Tamborino
1Research in Dosimetric Applications, Belgian Nuclear Research Centre, Mol, Belgium;
2Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yann Perrot
3IRSN, Institut de Radioprotection et de Sûreté Nucléaire, Fontenay aux Roses, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marijke De Saint-Hubert
1Research in Dosimetric Applications, Belgian Nuclear Research Centre, Mol, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lara Struelens
1Research in Dosimetric Applications, Belgian Nuclear Research Centre, Mol, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Nonnekens
2Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands;
4Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion De Jong
2Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark W. Konijnenberg
2Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Villagrasa
4Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Cellular morphologies. (A) 4Pi confocal microscope images with corresponding polygonal mesh structures. (B) Example of cell population representing modeled planar cellular cluster in Geant 4 (perspective view) where all cells are identical. Nucleus, G, and Cy are represented in blue/purple, green, and red, respectively. Cell population models reproduce confluence level of 50% ± 5%, estimated from radiobiologic observations. Geometric characteristics of the 3 cells are reported in Table 1.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Immunofluorescent staining of U2OS-SSTR2 cells and corresponding simulation hypotheses. (A) From left to right, images report nucleus, G, and SSTR2 stainings for untreated cells (top) and cells incubated with DOTATATE (bottom). Merged image at end highlights colocalization of SSTR2 with G after 1 h of incubation with DOTATATE. Scale bar = 5 µm. (B) Example of internalized source simulation for cell morphology 2. Nucleus, G, and Cy are reported in green, light blue, and light gray, respectively. Electron tracks are drawn in red, with yellow energy deposition points, which become blue when traversing nucleus.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Comparison between probabilities (A) and number (B) of SPs entering nucleus for 3 cell models, as indicated by x-axis, and the 3 source localizations (Cy, G [including contribution of CM], and medium when comparable to cell sources), including planar cross-irradiation. Number of particles entering nucleus refers to 2.5 MBq/mL of added activity to which experimental data correspond. Medium contribution is assumed to be same for the 3 morphologies on basis of simulations for cell 1. Each graph is subdivided into 2 windows corresponding to the 2 emission types (β and IC), as indicated by titles. N = nucleus.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Simulation results and graphical explanation. (A) DSB-yield (DSBs/Gbp SP) comparison for the 3 cell morphologies (as indicated by x-axis), the 3 source localizations (Cy, G [including contribution of CM], and medium), and the 2 emission types. Medium contribution is assumed to be same for the 3 morphologies on basis of simulations for cell 1. (B) Total nucleus irradiation (i.e., self- and cross-irradiation) characterizing nucleus 3 when IC electrons are emitted from G. (C) Total nucleus irradiation (i.e., self- and cross-irradiation) characterizing nucleus 1 when IC electrons are emitted from G. Color bars indicate energy (keV) at entrance of nucleus.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Energy spectra of electrons entering nucleus of the 3 cell morphologies. (A) Distributions corresponding to β particles. (B) Distributions corresponding to IC electrons. Each color corresponds to the 3 source localizations (Cy, G [including contribution of CM], and medium). Dotted lines indicate mean value of energy spectra. Spectrum of medium is assumed to be same as cell 1 for the 3 morphologies and is replicated in each graph for comparison with cell sources. Energy bin is 10 keV.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Probability density functions of energy deposited per particle in nucleus of the 3 cell morphologies. Each distribution corresponds to the 3 source localizations (Cy, G [including contribution of CM], and medium) and the 2 emission types (β and IC). Dotted lines indicate mean value of microscopic energy distributions, from which mean specific energy (Embedded Image) is evaluated (Table 2). Spectrum of medium is assumed to be same as cell 1 for the 3 morphologies and is replicated in each graph for comparison with cell sources.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    DSB simulations, comparison with experimental data, and correlation with absorbed dose to nucleus. (A) Simulated number of DSBs per nucleus corresponding to the 3 cell morphologies and internalization hypotheses (Cy vs. G, including CM), indicating contribution of each particle type (β and IC electrons). (B) Simulated DSBs per nucleus corresponding to the 3 cell morphologies and internalization hypotheses (Cy vs. G, including CM), indicating contribution of medium or cell source (internalized and membrane-bound). (C) Frequency histogram of experimental number of DSBs per nucleus induced by 4 h of administration of 2.5 MBq/mL activity of 177Lu-DOTATATE, measured by 53BP1. (D) Linear correlations between absorbed dose to nuclei and simulated number of DSBs when internalized source is located in Cy and in G. DAPI = 4′,6-diamidino-2-phenylindole.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Geometric Characteristics of the 3 Cell Morphologies

    Volume (μm3)
    ParameterCell 1Cell 2Cell 3
    Cy3,465.641,876.584,228.08
    G68.4624.3463.18
    Nucleus811.79714.711,105.84
    Size* (μm)
     CyBounding box: x = 72.24, y = 31.78, z = 5.99Bounding box: x = 99.21, y = 30.86, z = 3.52Bounding box: x = 88.70, y = 64.28, z = 6.29
     NucleusEllipsoid: a = 12, b = 8.5, c = 1.9Elliptic cylinder: a = 13, b = 7, c = 1.25Elliptic cylinder: a = 8, b = 11, c = 2
    • * Reported in half-dimensions for nucleus.

    • CM thickness = 0.0075 μm (42,43).

    • View popup
    TABLE 2.

    Mean Specific Energy per Particle Entering Nucleus of the 3 Cell Morphologies

    Embedded Image (Gy)
    ParameterCell 1Cell 2Cell 3
    Cy β1.240.991.27
    G β1.291.100.92
    Cy IC1.201.021.36
    G IC1.441.200.94
    Medium β0.52
    Medium IC0.69
    • Medium values (β and IC electrons) are calculated for nucleus 1 and assumed same for the 3 morphologies.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (5)
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
Giulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, Lara Struelens, Julie Nonnekens, Marion De Jong, Mark W. Konijnenberg, Carmen Villagrasa
Journal of Nuclear Medicine May 2022, 63 (5) 761-769; DOI: 10.2967/jnumed.121.262610

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
Giulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, Lara Struelens, Julie Nonnekens, Marion De Jong, Mark W. Konijnenberg, Carmen Villagrasa
Journal of Nuclear Medicine May 2022, 63 (5) 761-769; DOI: 10.2967/jnumed.121.262610
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Efficacy of [67Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2-Positive Neuroendocrine Tumors
  • Google Scholar

More in this TOC Section

  • [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
  • Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET
Show more Translational

Similar Articles

Keywords

  • DNA double-strand break simulation
  • targeted radionuclide therapy
  • 177Lu-DOTATATE
  • dose–effect relationship
  • Geant4-DNA
SNMMI

© 2025 SNMMI

Powered by HighWire